McDonald's is considering new protein-based products to win over GLP-1 drug users and says that many of its current items are already proving attractive to them.
Why it matters: The food industry is scrambling to adjust to a market in which about 1 in 8 American adults are taking the medication to treat obesity or diabetes, changing their eating habits.
Congress may be going home to campaign — but not before laying the groundwork for possible changes to how Medicare pays doctors.
Why it matters: Wary of yet another headache for patients and physicians, lawmakers are growing more receptive to addressing a long-running complaint about the way the program reimburses physicians.
The National Council on Problem Gambling issued a strongly worded warning Tuesday about the harms from prediction markets, taking a firmer stance on the industry following months of criticism for its initial handling.
Why it matters: Kalshi joined the nonprofit in May — the first prediction market to do so — setting off concerns among some problem gambling groups over NCPG's approach to the fast growing industry.
The willingness to confront powerful health care interests is becoming a litmus test for candidates in congressional battleground races with six weeks to go before the midterm elections.
Why it matters: Forget the old Affordable Care Act wars. Anxiety over health care costs is driving a new brand of populism, as Republicans and Democrats try to outdo each other with tough messages about taking on drug companies, insurers, pharmacy benefit managers and other industries.
